Chandra Adams - 01 Nov 2022 Form 4 Insider Report for Surface Oncology, Inc.

Role
Deputy GC
Signature
/s/ Jessica Fees, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Nov 2022
Net transactions value
$0
Form type
4
Filing time
03 Nov 2022, 20:05:11 UTC
Previous filing
03 Nov 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SURF Stock Option (Right to Buy) Award $0 +30,000 $0.000000 30,000 01 Nov 2022 Common Stock 30,000 $1.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal monthly installments over four years following October 17, 2022, so that all of the underlying shares shall be vested on October 17, 2026, so long as the reporting person remains an employee or other service provider of the Issuer on such dates.